||
Stevens-Johnson-syndroom (aandoening)
Stevens-Johnson-syndroom
syndroom van Stevens-Johnson
SJS
Stevens-Johnson syndrome
Stevens Johnson syndrome
A limited form of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum characterized by destruction and detachment of the skin epithelium, involving less than 10% of the body surface area, and mucous membranes. Onset usually occurs 4-28 days after administration of the causal medication and is most frequently associated with anticonvulsants, antibacterial sulfonamides, allopurinol, nevirapine, and oxicams (non-steroidal anti-inflammatory drugs), but many other medications have also been implicated. The disease is not induced by medication in 15% of cases. Histology is characterized by an epidermal necrolysis. Multiple disabling long-term sequelae (especially cutaneous, ocular and psychological) are frequent.
Id73442001
StatusPrimitive
Associated morphologynecrose
Finding sitestructuur van huid
Pathological processproces van overgevoeligheid
Associated morphologyerytheem
Finding sitestructuur van huid
Pathological processproces van overgevoeligheid
Associated morphologydiastase
Finding sitestructuur van huid en/of slijmvlies
Pathological processproces van overgevoeligheid
PALGA thesaurus simple reference set for pathology
Global Patient Set
International Patient Summary
DHD Diagnosis thesaurus reference set
SNOMED CT to Orphanet simple map36426
SNOMED CT to MedDRA simple map10042033
SNOMED CT to ICD-10 extended map
TargetL51.1
RuleTRUE
AdviceALWAYS L51.1 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified
|